Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2003 Feb;111(3):317-8.
doi: 10.1172/JCI17746.

HIV protease inhibitors and atherosclerosis

David Y Hui  1
Affiliations
Review

HIV protease inhibitors and atherosclerosis

David Y Hui. J Clin Invest. 2003 Feb.
No abstract available

PubMed Disclaimer

Figures

Figure 1
Figure 1
Schematic diagram depicting mechanisms by which HIV protease inhibitors may promote atherosclerosis through increased accumulation of SREBP. pSREBP, precursor form of SREBP; mSREBP, mature form of SREBP.
See this image and copyright information in PMC

Comment on

References

    1. Carr A, Samaras K, Chisholm DJ, Cooper DA. Pathogenesis of HIV-1 protease inhibitor-associated peripheral lipodystrophy, hyperlipidaemia, and insulin resistance. Lancet. 1998;351:1881–1883. - PubMed
    1. Henry K, et al. Severe premature coronary artery disease with protease inhibitors. Lancet. 1998;351:1328. - PubMed
    1. Jahoor F, et al. The acute-phase protein response to human immunodeficiency virus infection in human subjects. Am. J. Physiol. 1999;276:E1092–E1098. - PubMed
    1. Dressman J, et al. HIV protease inhibitors promote atherosclerotic lesion formation independent of dyslipidemia by increasing CD36-dependent cholesteryl ester accumulation in macrophages. J. Clin. Invest. 2003;111:389–397. doi:10.1172/JCI200316261. - PMC - PubMed
    1. Febbraio M, Hajjar DP, Silverstein RL. CD36: a class scavenger receptor involved in angiogenesis, atherosclerosis, inflammation, and lipid metabolism. J. Clin. Invest. 2001;108:785–791. doi:10.1172/JCI200114006. - PMC - PubMed